259 related articles for article (PubMed ID: 9512550)
1. E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.
Kilbourne EJ; Evans MJ; Karathanasis SK
Nucleic Acids Res; 1998 Apr; 26(7):1761-8. PubMed ID: 9512550
[TBL] [Abstract][Full Text] [Related]
2. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing.
Harnish DC; Evans MJ; Scicchitano MS; Bhat RA; Karathanasis SK
J Biol Chem; 1998 Apr; 273(15):9270-8. PubMed ID: 9535920
[TBL] [Abstract][Full Text] [Related]
3. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
Sandmöller A; Meents H; Arnold HH
Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
[TBL] [Abstract][Full Text] [Related]
4. Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acid.
Widom RL; Rhee M; Karathanasis SK
Mol Cell Biol; 1992 Aug; 12(8):3380-9. PubMed ID: 1321332
[TBL] [Abstract][Full Text] [Related]
5. The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements.
Liétard J; Théret N; Rehn M; Musso O; Dargère D; Pihlajaniemi T; Clément B
Hepatology; 2000 Dec; 32(6):1377-85. PubMed ID: 11093745
[TBL] [Abstract][Full Text] [Related]
6. Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3.
Harnish DC; Malik S; Karathanasis SK
J Biol Chem; 1994 Nov; 269(45):28220-6. PubMed ID: 7961760
[TBL] [Abstract][Full Text] [Related]
7. HNF3beta and GATA-4 transactivate the liver-enriched homeobox gene, Hex.
Denson LA; McClure MH; Bogue CW; Karpen SJ; Jacobs HC
Gene; 2000 Apr; 246(1-2):311-20. PubMed ID: 10767553
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-mediated regulation of smooth muscle alpha-actin gene transcription in fibroblasts and vascular smooth muscle cells involves multiple adenovirus E1A-interacting cofactors.
Wang SX; Elder PK; Zheng Y; Strauch AR; Kelm RJ
J Biol Chem; 2005 Feb; 280(7):6204-14. PubMed ID: 15576380
[TBL] [Abstract][Full Text] [Related]
9. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
Sang N; Avantaggiati ML; Giordano A
J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the mouse ferritin H gene. Involvement of p300/CBP adaptor proteins in FER-1 enhancer activity.
Tsuji Y; Moran E; Torti SV; Torti FM
J Biol Chem; 1999 Mar; 274(11):7501-7. PubMed ID: 10066817
[TBL] [Abstract][Full Text] [Related]
11. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2.
Somasundaram K; Jayaraman G; Williams T; Moran E; Frisch S; Thimmapaya B
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3088-93. PubMed ID: 8610173
[TBL] [Abstract][Full Text] [Related]
12. Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4.
Ginsburg GS; Ozer J; Karathanasis SK
J Clin Invest; 1995 Jul; 96(1):528-38. PubMed ID: 7615825
[TBL] [Abstract][Full Text] [Related]
13. Hepatic nuclear factor 3 and nuclear factor 1 regulate 5-aminolevulinate synthase gene expression and are involved in insulin repression.
Scassa ME; Guberman AS; Ceruti JM; Cánepa ET
J Biol Chem; 2004 Jul; 279(27):28082-92. PubMed ID: 15123725
[TBL] [Abstract][Full Text] [Related]
14. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
[TBL] [Abstract][Full Text] [Related]
15. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.
Furlong EE; Rein T; Martin F
Mol Cell Biol; 1996 Oct; 16(10):5933-45. PubMed ID: 8816507
[TBL] [Abstract][Full Text] [Related]
16. TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein.
Tsang SX; Morris GF; Lu M; Morris CB
Oncogene; 1996 Feb; 12(4):819-26. PubMed ID: 8632904
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region.
Costa RH; Grayson DR
Nucleic Acids Res; 1991 Aug; 19(15):4139-45. PubMed ID: 1870969
[TBL] [Abstract][Full Text] [Related]
18. An essential role for p300/CBP in the cellular response to hypoxia.
Arany Z; Huang LE; Eckner R; Bhattacharya S; Jiang C; Goldberg MA; Bunn HF; Livingston DM
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12969-73. PubMed ID: 8917528
[TBL] [Abstract][Full Text] [Related]
19. Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3.
Chen M; Hieng S; Qian X; Costa R; Ou JH
Virology; 1994 Nov; 205(1):127-32. PubMed ID: 7975208
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation.
Boyd JM; Loewenstein PM; Tang Qq QQ; Yu L; Green M
J Virol; 2002 Feb; 76(3):1461-74. PubMed ID: 11773419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
